Avantor, Inc.
No SEC Form 4 filings for $AVTR in the last 30 days.
Avantor Inc. (NYSE: AVTR) raised its full-year 2026 outlook after Q2 results beat expectations. Q2 net sales were $1.69B, up 0.5% YoY, with organic revenue down 0.4% (ex FX). Adjusted EPS was $0.21. Net income fell to $38.1M. Operating cash flow was $178.2M, free cash flow $142.8M, and $112.1M debt was repaid.
Avantor’s Q2 results beat Wall Street on revenue and non-GAAP earnings, with management citing progress in its Revival transformation, especially in the VWR distribution and services segment. CEO Emmanuel Ligner and CFO Steve Eck discussed drivers like e-commerce upgrades, contract wins, digital metrics, margin stability, and free cash flow. Revenue was $1.69B vs $1.61B est, adjusted EPS $0.21 vs $0.19, and full-year adjusted EPS guidance $0.82.
Avantor (AVTR) reported Q2 2026 sales of $1,692.3M, slightly up, but GAAP net income fell to $38.1M and EPS to $0.06. The company raised full-year 2026 guidance based on better-than-expected adjusted results and earlier organic growth in VWR Distribution & Services. The article also cites 2029 projections of $6.9B revenue and $566.4M earnings.
Over the past 7 days, alphai's AI scored 3 news stories mentioning AVTR (Avantor, Inc.). Coverage has skewed bullish: 3 bullish, 0 neutral, and 0 bearish.
Recent AVTR coverage spans earnings and market movers.
Guidance lift plus strong cash flow and debt repayment should support sentiment, but segment organic declines and profit drop temper upside.
The article provides a fresh earnings-and-guidance datapoint for AVTR, supporting a near-term re-rate thesis if investors believe Revival and VWR digital initiatives sustain momentum.
Guidance lift can support the stock near term, but the article flags ongoing GAAP profitability and cash-generation strain plus elevated leverage as key risks.
Results beat expectations and guidance was updated, with strong free cash flow used to repay $112.1M of debt.
Guidance raise and leverage target reduction suggest improving fundamentals, supporting a constructive near-term risk view versus prior expectations.
alphai scores every news story that mentions AVTR with an AI model for sentiment and relevance, and aggregates insider trades from Avantor, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Avantor Inc. (NYSE: AVTR) raised its full-year 2026 outlook after Q2 results beat expectations. Q2 net sales were $1.69B, up 0.5% YoY, with organic revenue down 0.4% (ex FX). Adjusted EPS was $0.21. Net income fell to $38.1M. Operating cash flow was $178.2M, free cash flow $142.8M, and $112.1M debt was repaid.
4 min readAvantor’s Q2 results beat Wall Street on revenue and non-GAAP earnings, with management citing progress in its Revival transformation, especially in the VWR distribution and services segment. CEO Emmanuel Ligner and CFO Steve Eck discussed drivers like e-commerce upgrades, contract wins, digital metrics, margin stability, and free cash flow. Revenue was $1.69B vs $1.61B est, adjusted EPS $0.21 vs $0.19, and full-year adjusted EPS guidance $0.82.
6 min readAvantor (AVTR) reported Q2 2026 sales of $1,692.3M, slightly up, but GAAP net income fell to $38.1M and EPS to $0.06. The company raised full-year 2026 guidance based on better-than-expected adjusted results and earlier organic growth in VWR Distribution & Services. The article also cites 2029 projections of $6.9B revenue and $566.4M earnings.
5 min readAvantor (NYSE: AVTR) reported Q2 FY2026 net sales of $1,692.3 million, up 0.5% year over year, with organic sales down 0.4%. Net income was $38.1 million, GAAP EPS $0.06, and adjusted EPS $0.21. Operating cash flow was $178.2 million and free cash flow $142.8 million. The company updated FY2026 guidance.
4 min readStrategic Execution and Performance Drivers Management attributes the second quarter outperformance to the 'Revival' program, which focuses on commercial excellence, operational performance, and organizational simplification. The VWR Distribution & Services segment returned to organic growth earlier than anticipated, driven by deliberate actions to strengthen large global customer relationships and improve e-commerce engagement.
7 min readSimply Wall St reports Avantor (AVTR) shares fell about 3.7% to around $13.86 after Q2 results. The company posted Q2 revenue of $1.69b and adjusted EPS of $0.21, with free cash flow of $152m and leverage near 3.3x. Revenue was roughly flat YoY, but net income fell about 41% YoY and trailing net income turned to a loss.
5 min readBiotech gainers included SciSparc (SPRC) after its subsidiary NeuroThera Labs completed internal validation of a quantum sampling platform. Avantor (AVTR) rose after Q2 results and raised 2026 adjusted EPS to $0.80-$0.83. NeoGenomics (NEO) lifted 2026 revenue guidance to $802-$806M. Other movers: Alvotech (ALVO) on FDA facility inspection, Sanara MedTech (SMTI) to be acquired by MiMedx (MDXG), and LB Pharmaceuticals (LBRX) after a ~$150M private placement.
3 min readUS equity futures edged higher as S&P 500 and Nasdaq 100 contracts were up about 0.2% premarket, despite a sharp Kospi selloff in Asia and a 5% oil jump. The article cites earnings and guidance moves for several companies, including MSFT and META, plus notable premarket moves: AVTR +4%, BE +8%, CAT -4%, and others. It also notes a Fed decision later today with markets pricing a 32% hike chance.
7 min readAvantor (NYSE:AVTR) reported Q2 CY2026 revenue of $1.69 billion, flat year over year but 4.9% above Wall Street estimates, according to the article. Non-GAAP adjusted EPS was $0.21, up 11% versus analysts’ consensus, though down from $0.24 a year earlier. The stock rose about 7% to $13.28 after the release.
4 min readAvantor shares rose about 4.7% in pre-market after the company reported Q2 results above analyst estimates. Adjusted diluted EPS was $0.21 versus $0.19 expected, and revenue was $1.69B versus $1.61B. Avantor also raised full-year 2026 adjusted EPS guidance to $0.80–$0.83 from prior expectations near $0.79, citing progress from its “Revival” program.
3 min read
